Bifidobacterium Breve Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Bifidobacterium Breve interacts with medications. The heart of this page is the interaction list — every drug Bifidobacterium Breve is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Bifidobacterium Breve is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Bifidobacterium Breve against your medication
Add one medicationBifidobacterium Breve Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a harmful, clinically significant Bifidobacterium Breve drug interaction appears low for most people, because the main concern is the supplement working less well rather than any medication becoming dangerous. None of the listed interactions are rated major, and every one of them involves the same single issue with antibiotic medicines.
The medications that deserve attention are antibiotics. Because Bifidobacterium breve products contain live bacteria, taking an antibiotic at the same time may kill many of those organisms and reduce the benefit you get from the probiotic. This concern is largely theoretical, but it applies broadly across antibiotic drugs, which is why so many individual medicines appear on the list.
The long list of interacting medications looks alarming at first, but it reflects one shared concern rather than many different risks. Nearly every entry is simply an antibiotic that could weaken the probiotic itself, not a drug whose safety or effect on your body is changed. No interactions in this profile suggest the supplement makes any medication stronger, weaker, or more toxic.
Based on HelloPharmacist’s Bifidobacterium Breve interaction data and reviewed under our editorial standards.
Drugs that interact with Bifidobacterium Breve
182 medications have a known interaction with Bifidobacterium Breve, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Bifidobacterium Breve using our pharmacist-reviewed interaction data.
AI summaries are generated from our Bifidobacterium Breve interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Bifidobacterium Breve combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Bifidobacterium Breve affects
Every type of medication (drug category) Bifidobacterium Breve is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Antibiotic Drugs
Theoretically, taking Bifidobacterium breve with antibiotic drugs might decrease the effectiveness of B. breve.
Since B. breve preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. breve preparations by at least 2 hours.
Bifidobacterium Breve: Uses, Safety & Side Effects
Bifidobacterium breve is a 'friendly' gut bacterium taken as a probiotic, most often to support digestion and balance the gut microbiome. Some studies suggest possible benefits for certain digestive and infant conditions, but evidence is still limited and varies by strain. It is generally well tolerated in healthy people, but anyone with a weak immune system or serious illness should check with a doctor or pharmacist first.
- Scientific name
- Bifidobacterium breve
- Family
- Bifidobacteriaceae
- Part used
- Live bacterial cells (probiotic strain)
- Common forms
- Capsules, powders, sachets, chewables, drops, and fortified foods or drinks
- Digestive health and regularity
- Infant colic and gut support
- Diarrhea (including antibiotic-related)
- Constipation
- General immune and gut microbiome support
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated in healthy people, but caution is needed for those who are very ill or immunocompromised.
There is insufficient reliable information available about the safety of Bifidobacterium breve during pregnancy or lactation. However, there are curre...
Read the full pregnancy detailThere is insufficient reliable information available about the safety of Bifidobacterium breve during pregnancy or lactation. However, there are curre...
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Bifidobacterium breve is a type of beneficial ("friendly") bacteria that naturally lives in the human gut. It is one of the first bacteria to colonize the intestines of breastfed infants and remains part of a healthy gut microbiome throughout life.
As a supplement, it is grown in controlled settings and sold as a probiotic. You can find it on its own or combined with other probiotic strains in capsules, powders, drops, and some fortified foods and drinks.
People take B. breve mainly to support digestion, help keep the gut microbiome balanced, and for general wellness. Like other probiotics, its effects can depend a lot on the specific strain and the product used.
How it works
As a probiotic, Bifidobacterium breve is thought to work by helping to balance the community of microbes in the gut. When taken, it may temporarily add to the population of helpful bacteria.
Proposed mechanisms, many based on laboratory and animal research, include:
- Producing short-chain fatty acids and other compounds that feed and protect the gut lining.
- Competing with potentially harmful bacteria for space and nutrients.
- Helping break down certain sugars and fibers during digestion.
- Interacting with the gut's immune cells in ways that may support a balanced immune response.
These effects are still being studied, and how strongly they apply in humans is not fully understood.
Does Bifidobacterium Breve work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Possibly Ineffective Age-related cognitive decline
Oral Bifidobacterium breve does not seem to improve cognition in older adults.
Possibly Ineffective Sepsis
Oral Bifidobacterium breve does not seem to prevent sepsis in preterm infants.
Also studied for 29 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Allergic rhinitis (hay fever)
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Antibiotic-associated diarrhea
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Aspirin-associated gastric damage
It is unclear if oral Bifidobacterium breve can reduce the risk of aspirin-associated gastric damage.
Insufficient Reliable Evidence To Rate Asthma
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Atopic dermatitis (eczema)
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Atopic disease
Although there has been interest in using oral Bifidobacterium breve for preventing and treating atopic disease, there is insufficient reliable information about the clinical effects of B. breve for this use.
Insufficient Reliable Evidence To Rate Celiac disease
Although there has been interest in using oral Bifidobacterium breve for celiac disease, there is insufficient reliable information about the clinical effects of B. breve for this condition.
Insufficient Reliable Evidence To Rate Chemotherapy-related infection
Although there has been interest in using oral Bifidobacterium breve for preventing chemotherapy-related infections, there is insufficient reliable information about the clinical effects of B. breve for this purpose.
Insufficient Reliable Evidence To Rate Clostridioides difficile infection
Although there has been interest in using oral Bifidobacterium breve for C. difficile infection, there is insufficient reliable information about the clinical effects of B. breve for this condition.
Insufficient Reliable Evidence To Rate Cognitive impairment
It is unclear if oral Bifidobacterium breve is beneficial for cognitive impairment.
Insufficient Reliable Evidence To Rate Colic
It is unclear if oral Bifidobacterium breve is beneficial for colic.
Insufficient Reliable Evidence To Rate Constipation
Most early research shows that oral Bifidobacterium breve seems to be beneficial for constipation.
Insufficient Reliable Evidence To Rate Diabetes
It is unclear if oral Bifidobacterium breve is beneficial for type 2 diabetes. For other forms of diabetes, oral B. breve has only been evaluated in combination with other ingredients, and its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Exercise-induced muscle soreness
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Helicobacter pylori
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Insomnia
It is unclear if oral Bifidobacterium breve is beneficial for insomnia.
Insufficient Reliable Evidence To Rate Irritable bowel syndrome (IBS)
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Metabolic syndrome
Although there has been interest in using oral Bifidobacterium breve for metabolic syndrome, there is insufficient reliable information about the clinical effects of B. breve for this condition.
Insufficient Reliable Evidence To Rate Necrotizing enterocolitis (NEC)
It is unclear if oral Bifidobacterium breve is beneficial or safe for preventing NEC.
Insufficient Reliable Evidence To Rate Nonalcoholic fatty liver disease (NAFLD)
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Obesity
It is unclear if oral Bifidobacterium breve is beneficial for obesity.
Insufficient Reliable Evidence To Rate Postoperative recovery
Although there has been interest in using oral Bifidobacterium breve for improving postoperative recovery, there is insufficient reliable information about the clinical effects of B. breve for this purpose.
Insufficient Reliable Evidence To Rate Postpartum depression
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Pouchitis
Oral Bifidobacterium breve has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Radiation-induced diarrhea
Although there has been interest in using oral Bifidobacterium breve for preventing radiation-induced diarrhea, there is insufficient reliable information about the clinical effects of B. breve for this purpose.
Insufficient Reliable Evidence To Rate Respiratory tract infections
It is unclear if oral Bifidobacterium breve is beneficial for the prevention of respiratory tract infections.
Insufficient Reliable Evidence To Rate Rotaviral diarrhea
Although there has been interest in using oral Bifidobacterium breve for rotaviral diarrhea, there is insufficient reliable information about the clinical effects of B. breve for this condition.
Insufficient Reliable Evidence To Rate Short bowel syndrome
Although there has been interest in using oral Bifidobacterium breve for short bowel syndrome, there is insufficient reliable information about the clinical effects of B. breve for this condition.
Insufficient Reliable Evidence To Rate Ulcerative colitis
It is unclear if oral Bifidobacterium breve is beneficial for ulcerative colitis.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
For most healthy people, Bifidobacterium breve is considered generally well tolerated when taken as directed. However, a few groups should be more careful.
Use caution or avoid if you have a weakened immune system, are seriously ill, have a central venous catheter, or are recovering from major surgery. In rare cases, live bacteria can cause infections in people who are very vulnerable. Premature infants should only receive probiotics under medical supervision.
Pregnancy and breastfeeding: Probiotics are often considered low-risk, but high-quality safety data are limited. To be safe, use B. breve during pregnancy or while breastfeeding only after talking with your doctor or pharmacist.
Always choose products from reputable manufacturers, since supplement quality is not tightly regulated.
Side effects
Bifidobacterium breve is usually well tolerated. The most common side effects are mild and digestive, such as:
- Gas or bloating
- Mild stomach discomfort
- Changes in bowel movements
These effects often ease as your body adjusts. Rare but serious problems, such as bloodstream infections, have been reported mostly in people who are critically ill or severely immunocompromised. Stop use and seek medical care if you develop a fever, severe stomach pain, or signs of infection.
Bifidobacterium Breve: Reported Adverse Effects
Documented safety reports on Bifidobacterium Breve from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Reports by conditionDiabetes Immunologic
There have been rare cases of Bifidobacterium bacteremia related to probiotic use in critically ill infants and adults. In addition, cases of B. breve bacteremia have occurred in preterm infants or young children using probiotics. In a review of 298 term and preterm infants who were admitted to the neonatal intensive care unit of a hospital in Japan and received B. breve BBG-01 over a five-year period, bacteremia occurred in six patients (2%). Concomitant conditions included gastrointestinal perforation, food-induced enterocolitis syndrome, adhesive ileus, ileal volvulus, and aspiration pneumonia following esophageal atresia repair. In one case report, B. breve BBG-01 was provided to an infant starting two days after birth and the day of surgery for an omphalocele. The infant also had bilious gastric fluid with elevated inflammatory markers. It is thought that the intestinal surgical repair might have led to the translocation of the ingested B. breve.
Some cases of B. breve bacteremia do not seem to be directly related to probiotic use. There have been rare cases of B. breve bacteremia and necrotizing fasciitis in patients with type 2 diabetes. One patient had pre-existing chronic diabetic foot ulcers and the other had abscesses near the groin. A childhood history of frequent consumption of fermented beverages containing B. breve was thought to have resulted in B. breve in the intestinal flora of one of these patients, aged 42 years. However, it is unclear if consumption of an unknown quantity of B. breve more than 20 years previously would play a role in this outcome. There is also a rare case of ventriculoperitoneal shunt B. breve infection possibly related to poor oral hygiene and dentition.
- Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
- Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65.
- Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7)
- Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-81.
- Wakabayashi Y, Nakayama S, Yamamoto A, et al. First case of necrotizing fasciitis and bacteremia caused by Bifidobacteriumbreve. Anaerobe 2022;76:102613.
- Takeda Y, Ota K, Kondo A, et al. A case of necrotizing fasciitis caused by Bifidobacterium breve. IDCases 2022;31:e01667.
- Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014;28:1-3.
Flatulence Gastrointestinal
Bloating and flatulence have been reported with probiotic use; however, these adverse effects have not been reported from ingestion of Bifidobacterium breve in particular.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single standard dose of Bifidobacterium breve. Probiotic amounts are usually measured in colony-forming units (CFU), and products vary widely in their strain and strength.
The best approach is to follow the directions on the product label, since dosing was often based on the specific strain studied. If you are unsure how much to take, or are using it for a child or an infant, check with your pharmacist or doctor first.
Store probiotics as directed (some need refrigeration) to keep the bacteria alive and effective.
Bifidobacterium Breve & Pregnancy
Bifidobacterium Breve & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 9 references that drive our Bifidobacterium Breve monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
- Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
- Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
- Ohishi A, Takahashi S, Ito Y, et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr. 2010;156(4):679-81. PubMed
- Sakurai Y, Watanabe T, Miura Y, et al. Clinical and bacteriologic characteristics of six cases of Bifidobacterium breve bacteremia due to probiotic administration in the neonatal intensive care unit. Pediatr Infect Dis J 2022;41(1):62-65. PubMed
- Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed
- Wakabayashi Y, Nakayama S, Yamamoto A, et al. First case of necrotizing fasciitis and bacteremia caused by Bifidobacteriumbreve. Anaerobe 2022;76:102613.
- Takeda Y, Ota K, Kondo A, et al. A case of necrotizing fasciitis caused by Bifidobacterium breve. IDCases 2022;31:e01667. PubMed
- Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014;28:1-3. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Bifidobacterium Breve
328 brands in our database make a supplement containing Bifidobacterium Breve.
Supplement products with Bifidobacterium Breve
1,796 products in our database contain Bifidobacterium Breve. Open any to see its full ingredient list and every drug interaction we check.
Bifidobacterium Breve: Common Questions
What is Bifidobacterium Breve used for, and does it work?
Does Bifidobacterium Breve interact with prescription medications?
How are Bifidobacterium Breve interactions rated?
Is it safe to take Bifidobacterium Breve with my medications?
Where does this Bifidobacterium Breve interaction information come from?
What is Bifidobacterium Breve used for?
Is Bifidobacterium Breve safe to take every day?
Can I give Bifidobacterium Breve to my baby?
Does it need to be refrigerated?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Bifidobacterium Breve
A rotating sample of real supplements in our database that list Bifidobacterium Breve — open any to see its full ingredients and every drug interaction we check.
- ProbioMax Complete DF by XYMOGEN
- Digestive Greens Tasty Mixed Berry Flavor by BIOHM
- Ultimate 10+ Probiotics 13 Billion by The Vitamin Shoppe
- Everyday Ultimate Flora Probiotic 15 Billion by Renew Life
- Men's 50 Billion Probiotics Delayed Release by ProBioCare
- Gut-Brain Connection Chocolate Flavored by BIOHM
- Super Reds Red Berry Flavor by BIOHM
- Tri Active Biotics by Essential Source
- Probiotics Occasional Constipation Support 20 Billion CFU by Renew Life
- Probiotic 101 Billion by Allegany Nutrition
Have a question about Bifidobacterium Breve?
Our pharmacists answer your medication & supplement questions — free.